Shedding Part 2- The Bio-Distribution and Excretion of Covid mRNA Vaccine Components and ProductsIn order to transmit or “shed” the Covid mRNA encapsulated lipid nanoparticle and/or the transcribed spike protein product, dissemination to organs and body fluids must occur. Does it? Answer: Yes.

PIERRE KORY, MD, MPA

OK, so in Part 1 of this series on Covid mRNA vaccine shedding, I provided evidence that:
The FDA and the EMA define the mRNA vaccines as gene therapies.
The FDA requires that gene therapy products undergo human shedding studies given the known risks of shedding
Shedding studies were not done because, even though the vaccines are gene-therapies, they legally fell under the legal definition of a “countermeasure” in a public health emergency. Countermeasures do not require shedding or other types of safety studies before mass use.
All we know is that from a FOIA obtained document, Pfizer did a shedding study on rats but we don’t know what they found.
HOW DOES SHEDDING OCCUR AND IS THERE ANY EVIDENCE OF IT OCCURRING WITH THE COVID mRNA VACCINES?
In order for the vaccine or spike to be shed, it would first require distribution of the vaccine components or spike protein product to the lungs (to then be exhaled) and other body fluids (to then be excreted)
To explore this possibility, it is important that we define what a lipid nanoparticle LNP) is, along with their natural, biological counterparts which are called exosomes or extracellular vesicles (EVs).